Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001311172 | SCV001501243 | uncertain significance | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | CACNA1A: PP3 |
Fulgent Genetics, |
RCV002499596 | SCV002805600 | uncertain significance | Episodic ataxia type 2; Spinocerebellar ataxia type 6; Migraine, familial hemiplegic, 1; Developmental and epileptic encephalopathy, 42 | 2021-09-28 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004734115 | SCV005348398 | likely benign | CACNA1A-related disorder | 2024-05-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |